mates. These Trk mutant mice allow specific, potent, outlined in Figures 1B-1D . Chimeric mice were oband reversible inhibition of Trk signaling and should be tained following blastocyst injection of targeted ES useful for both in vivo and in vitro studies addressing cells, and the neomycin resistant cassettes used for ES neurotrophin functions in the developing and adult nercell selection were excised upon crossing the chimeric vous system. Figure 2D ). This result indicates that K252a and PP1 derivatives may interact with common a high concentration of this compound does not affect wild-type Trk receptor signaling. residues within the TrkB ATP binding pocket and that the F616A mutation may diminish K252a binding to TrkB.
1NMPP1 Inhibition Is Stable and Reversible In Vitro
One of the appealing advantages of using competitive Side-by-side drug efficacy comparisons were thus carried out with the most potent PP1 derivatives, inhibitors to study enzyme function is the reversible nature of their action, which in the case of 1NMPP1 may 1NMPP1 and 1NaPP1. Both drugs were found to potently and specifically inhibit TrkB F616A kinase activity allow precise temporal control over Trk F-A signaling.
To assess the extent of reversibility of 1NMPP1-mediin cortical neurons cultured from either wild-type or TrkB F616A mutant embryos ( Figure 3A ; data not shown). ated inhibition of TrkB F616A signaling in cortical neurons, we first exposed TrkB 
TrkB
F616A is reversible ( Figure 4A ). Additionally, in conin vitro stability experiments indicate that a single application of 1NMPP1 (100 nM) to cultured neurons led to trast to the commonly used nonselective Trk inhibitor K252a, which requires replenishment every 12 to 24 hr, sustained inhibition of TrkB F616A signaling for at least 3 days, the duration of the experiment ( Figure 4B ). These results, taken together, indicate that 1NMPP1 is a potent, specific, stable, and reversible inhibitor of TrkA F592A and TrkB F616A signaling in neurons.
1NMPP1 Inhibits Neurotrophin Signaling in Trk F-A Mice In Vivo
We next sought to determine the efficacy and specificity of 1NMPP1 inhibition of Trk F-A signaling in vivo. We reasoned that 1NMPP1 application to TrkA F592A , TrkB F616A , and TrkC F617A embryos, but not to their wild- 
